Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Alembic Pharmaceuticals Ltd

APLLTD:NSI

Alembic Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,114.80
  • Today's Change29.80 / 2.75%
  • Shares traded19.55k
  • 1 Year change+56.35%
  • Beta0.6775
Data delayed at least 15 minutes, as of Nov 01 2024 13:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

  • Revenue in INR (TTM)63.04bn
  • Net income in INR6.30bn
  • Incorporated2010
  • Employees14.86k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Strides Pharma Science Ltd44.10bn1.77bn143.04bn3.07k80.936.2938.483.2419.2225.15479.84247.160.71551.503.5714,389,290.002.79-1.685.43-2.9760.1951.393.91-3.360.63551.520.5103--9.8313.2143.57---18.52-3.58
Caplin Point Laboratories Ltd17.58bn4.78bn154.71bn859.0032.48--28.648.8062.6762.67230.62--------20,462,630.00--19.83--22.8258.4153.3827.4325.39--1,525.59--9.0615.5021.1721.4820.9517.4717.84
Sanofi India Ltd23.83bn4.30bn156.48bn2.17k36.4122.8633.446.57186.62229.861,034.61297.261.672.7315.6010,960,440.0030.0822.4257.5530.2155.9555.5218.0421.030.8140435.860.0313135.492.920.573-2.859.64-10.3414.73
Eris Lifesciences Ltd24.98bn3.48bn180.09bn3.08k51.746.4928.917.2125.5725.57183.35203.740.45852.905.968,110,753.006.7313.428.3916.8077.0379.9814.6924.960.85993.410.4626--19.2315.392.576.1527.72--
Wockhardt Ltd28.93bn-3.43bn185.39bn2.39k------6.41-23.75-23.75199.60--------12,084,380.00---4.56---8.2958.6655.26-12.17-12.70--0.0764----5.55-4.7317.17---4.71--
Neuland Laboratories Ltd.16.35bn3.36bn187.40bn1.65k55.76--47.0311.46261.94261.941,274.50--------9,922,259.00--9.25--12.7153.3247.8120.5511.99--29.52--7.1330.8418.5183.5178.7617.8863.45
Astrazeneca Pharma India Ltd13.88bn958.59m190.62bn940.00198.86--171.8713.7438.3438.34555.18--------14,761,520.00--11.78--19.6248.5154.646.9110.27--121.25--25.6229.1712.2162.6624.29-10.46--
Concord Biotech Ltd10.38bn3.13bn191.48bn1.38k61.15--52.1818.4529.9329.9399.19--------7,537,496.00--------77.16--30.18----115.93----19.20--28.33------
Jubilant Pharmova Ltd69.20bn5.93bn191.94bn995.0032.413.2319.862.7737.3837.38436.41375.040.59341.758.1569,544,720.005.052.966.013.5568.5068.478.515.131.202.510.34224.736.70-5.95226.43-33.086.482.13
Alembic Pharmaceuticals Ltd63.04bn6.30bn221.89bn14.86k35.23--24.513.5232.0432.04320.63--------4,242,974.00--10.72--14.2573.1065.989.9912.47--12.52--28.2910.199.6280.071.05-15.5914.87
Pfizer Ltd22.38bn6.18bn233.22bn1.72k37.756.2234.3610.42135.06135.06489.19819.900.52881.8311.1613,004,360.0014.6014.2217.0517.7165.0061.3727.6124.054.3046.210.026782.67-9.551.05-11.645.1433.359.24
Natco Pharma Ltd.42.21bn16.37bn251.28bn4.02k15.35--13.785.9591.3791.37235.68--------10,510,210.00--12.33--14.2583.4073.0538.7725.16--91.13--18.9647.7213.8194.0916.59-4.7114.87
Laurus Labs Ltd50.53bn1.31bn264.86bn6.01k201.926.4048.585.242.432.4393.7076.700.6021.183.068,412,186.001.5510.132.5216.4753.4447.632.5812.830.58181.810.402313.00-16.5517.07-79.6811.3621.6821.67
Gland Pharma Ltd58.58bn7.22bn272.02bn4.22k37.67--24.884.6443.8343.83355.57--------13,890,770.00--13.23--14.5661.0055.5812.3322.92--34.66--7.2656.2922.61-1.1011.3224.02--
Emcure Pharmaceuticals Ltd-100.00bn-100.00bn272.13bn11.15k--------------------------7.14--13.93--59.29--7.81------0.0011.237.14-6.3621.35-5.93--
J B Chemicals and Pharmaceuticals Ltd35.92bn5.87bn304.58bn5.31k53.02--41.458.4836.9936.99226.16--------6,764,044.00--15.77--18.8966.2761.1816.3416.06--21.04--33.0810.6316.2234.8423.3640.1537.42
Data as of Nov 01 2024. Currency figures normalised to Alembic Pharmaceuticals Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

14.24%Per cent of shares held by top holders
HolderShares% Held
Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 20248.50m4.33%
DSP Asset Managers Pvt. Ltd.as of 30 Sep 20248.25m4.20%
Kotak Mahindra Asset Management Co. Ltd.as of 30 Sep 20243.72m1.89%
The Vanguard Group, Inc.as of 02 Oct 20241.80m0.92%
Axis Asset Management Co. Ltd.as of 30 Sep 20241.45m0.74%
Dimensional Fund Advisors LPas of 03 Oct 20241.18m0.60%
Edelweiss Asset Management Ltd.as of 30 Sep 20241.10m0.56%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Sep 2024755.96k0.39%
BlackRock Fund Advisorsas of 03 Oct 2024747.74k0.38%
Baroda BNP Paribas Asset Management India Pvt Ltd.as of 30 Sep 2024482.98k0.25%
More ▼
Data from 30 Jun 2024 - 24 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.